Genprex GNPX
NASDAQ GNPX
$2.03 -0.02 (-1.22%)
As of: Oct 22, 2026 · 11:15 AM EDT

Genprex (GNPX) EPS (Basic) (2016 - 2026)

Updated

Genprex (GNPX) reported EPS (Basic) of -$14.12 for Q1 2026, compared with -$5.71 a year earlier.

Analysis

Genprex (GNPX) EPS (Basic) (2016 - 2026) Analysis & Trends

Over the twelve months ended Mar 31, 2026, Genprex's EPS (Basic) came in at -$55.16; for FY2024, it came in at -$117.46.

  • By year, EPS (Basic) came in at -$496.39 in FY2023, -$10.89 in FY2022, -$9.65 in FY2021 and -$11.11 in FY2020.
  • The Q1 2026 figure ranks as the lowest quarterly EPS (Basic) since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,172.45 Bn 1,141.04 Bn 19.71 Bn 7.95
2 Johnson & Johnson 637.59 Bn 556.11 Bn 17.26 Bn 2.30
3 AbbVie 504.05 Bn 477.16 Bn 12.70 Bn 2.04
4 Merck 377.18 Bn 331.56 Bn 12.21 Bn -0.54
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn 1.68
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn 1.62
7 Amgen 241.83 Bn 197.23 Bn 7.24 Bn 4.40
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn -8.44
9 Pfizer 172.51 Bn 119.15 Bn 10.94 Bn -0.04
10 Genprex 958,153.10 -41.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.12
Jun 30, 2025 -3.73
Mar 31, 2025 -5.71
Dec 31, 2024 -23.78
Sep 30, 2024 -27.13
Jun 30, 2024 -66.10
Mar 31, 2024 -81.15
Dec 31, 2023 -95.37
Sep 30, 2023 -2.95
Jun 30, 2023 -3.38
Mar 31, 2023 -4.09
Dec 31, 2022 -2.99
Sep 30, 2022 -2.82
Jun 30, 2022 -2.65
Mar 31, 2022 -2.44
Dec 31, 2021 -3.15
Sep 30, 2021 -1.59
Jun 30, 2021 -1.85
Mar 31, 2021 -2.56
Dec 31, 2020 -3.24
API Access

Genprex EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=GNPX&period=max&api_key=YOUR_API_KEY